Continuum Advisory’s Ingevity NGVT Stock Holding History

Continuum Advisory’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-57	Closed	-$2.26K	–	1161
2025 Q1	$2.26K	Buy	+57	New	+$2.52K	﹤0.01%	1316

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Continuum Advisory's NGVT Position: Q2 2025 in Review

Continuum Advisory sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 57 shares — an estimated $2.26K sold.

Continuum Advisory first reported a position in NGVT in Q1 2025 and held it in 1 quarter. The position peaked at $2.26K in Q1 2025. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

Continuum Advisory reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
Continuum Advisory sold 57 Ingevity shares in Q2 2025, an estimated $2.26K.
Continuum Advisory first reported a position in Ingevity in Q1 2025 and held it in 1 quarter.
Continuum Advisory's Ingevity position peaked at $2.26K in Q1 2025.
269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.